Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-gdtc
/
CytoMed Therapeutics Ltd
GDTC
1.865
USD
+0.035
+1.91%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
21.50M
Market Cap
--
P/E TTM
CytoMed Therapeutics Ltd
1.865
+0.035
+1.91%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
Total equity
Cash, cash equivalents and short-term investments
-44.74%
4.97M
-38.00%
6.47M
469.41%
9.00M
601.86%
10.44M
-37.13%
1.58M
-61.83%
1.49M
--
2.51M
--
3.90M
- Cash and cash equivalents
-44.74%
4.97M
-38.00%
6.47M
469.41%
9.00M
601.86%
10.44M
-37.13%
1.58M
-61.83%
1.49M
--
2.51M
--
3.90M
Receivables
-40.80%
121.21K
-57.51%
48.84K
255.58%
204.75K
766.55%
114.94K
988.51%
57.58K
1830.71%
13.26K
--
5.29K
--
687.00
-Accounts and notes receivable
--
18.78K
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-Loans receivable
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
--
-Other receivables
-51.39%
99.53K
-57.51%
48.84K
255.58%
204.75K
1143.93%
114.94K
988.51%
57.58K
1244.98%
9.24K
--
5.29K
--
687.00
Inventory
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
320.85K
Prepaid expenses
4.89%
878.67K
-6.47%
835.89K
-0.39%
837.73K
30.74%
893.71K
12.37%
841.00K
12.81%
683.56K
--
748.45K
--
605.92K
Other current assets
-48.45%
30.46K
1467.53%
351.22K
279.66%
59.08K
45.94%
22.41K
2.17%
15.56K
48.12%
15.35K
--
15.23K
--
10.37K
Total current assets
-40.57%
6.00M
-32.80%
7.71M
304.86%
10.10M
421.47%
11.47M
-24.01%
2.49M
-54.50%
2.20M
--
3.28M
--
4.83M
Non-current assets
Net Fixed Assets
57.55%
3.25M
12.09%
2.48M
-16.57%
2.06M
-17.57%
2.21M
-0.83%
2.47M
26.60%
2.68M
--
2.50M
--
2.12M
-Fixed Assets
46.38%
5.02M
--
--
-2.78%
3.43M
--
--
9.10%
3.53M
32.90%
3.58M
--
3.23M
--
2.70M
-Accumulated depreciation
29.47%
1.77M
--
--
29.63%
1.36M
--
--
42.71%
1.05M
56.11%
898.01K
--
737.67K
--
575.24K
Goodwill and other intangible assets
649.62%
93.05K
-20.29%
11.01K
-34.00%
12.41K
-45.64%
13.81K
-41.26%
18.81K
-34.22%
25.41K
--
32.02K
--
38.63K
Total non-current assets
78.99%
4.07M
30.91%
3.20M
-16.87%
2.27M
-17.20%
2.45M
-2.41%
2.73M
36.83%
2.95M
--
2.80M
--
2.16M
Total assets
-18.60%
10.07M
-21.60%
10.91M
136.63%
12.37M
170.01%
13.91M
-14.06%
5.23M
-26.30%
5.15M
--
6.08M
--
6.99M
Liabilities
Current liabilities
-Other payables
-27.49%
38.70K
59.06%
29.80K
-67.57%
53.37K
-67.52%
18.74K
520.69%
164.59K
120.16%
57.70K
--
26.52K
--
26.21K
Accrued expenses
-18.57%
363.69K
29.39%
241.57K
88.31%
446.63K
103.70%
186.70K
62.49%
237.18K
-26.86%
91.66K
--
145.97K
--
125.32K
Short-term debt and lease liabilities
14.07%
45.91K
-8.73%
37.39K
-98.92%
40.25K
-98.56%
40.96K
38.44%
3.74M
10.87%
2.84M
--
2.70M
--
2.56M
-Short-term debt
--
0.00
--
--
-100.00%
0.00
-100.00%
0.00
39.10%
3.70M
11.17%
2.80M
--
2.66M
--
2.52M
-Short-term lease liabilities
30.65%
8.26K
--
--
-17.98%
6.32K
-3.86%
7.51K
-1.32%
7.71K
2.35%
7.81K
--
7.81K
--
7.63K
Deferred liabilities
1874.74%
107.74K
-21.57%
4.32K
55.71%
5.46K
-58.02%
5.50K
-74.03%
3.50K
-2.80%
13.11K
--
13.49K
--
13.49K
Other current liabilities
148.93%
146.44K
32.46%
34.12K
-65.33%
58.83K
-63.62%
25.76K
324.13%
169.69K
78.38%
70.81K
--
40.01K
--
39.70K
Total current liabilities
-15.39%
606.62K
13.67%
357.92K
-82.79%
716.94K
-89.76%
314.88K
41.84%
4.17M
9.87%
3.07M
--
2.94M
--
2.80M
Non-current liabilities
Long-term debt and lease liabilities
-3.30%
394.31K
-8.80%
390.90K
-13.02%
407.77K
-15.72%
428.61K
-13.04%
468.83K
-9.14%
508.58K
--
539.12K
--
559.71K
-Long-term debt
-3.30%
394.31K
-8.80%
390.90K
-13.02%
407.77K
-15.72%
428.61K
-13.04%
468.83K
-9.14%
508.58K
--
539.12K
--
559.71K
Total non-current liabilities
2.35%
417.34K
-9.35%
390.90K
-14.25%
407.77K
-17.01%
431.19K
-14.23%
475.54K
-10.26%
519.58K
--
554.44K
--
578.98K
Total liabilities
-8.96%
1.02M
0.37%
748.82K
-75.76%
1.12M
-79.24%
746.07K
32.94%
4.64M
6.42%
3.59M
--
3.49M
--
3.38M
Shareholders' equity
Common equity
0.00%
23.79M
0.31%
23.79M
166.96%
23.79M
208.44%
23.72M
15.90%
8.91M
0.00%
7.69M
--
7.69M
--
7.69M
Retained earnings
-19.81%
-14.77M
-29.58%
-13.42M
-50.41%
-12.33M
-70.83%
-10.36M
-61.79%
-8.20M
-50.03%
-6.06M
--
-5.07M
--
-4.04M
Capital reserves
--
--
--
0.00
--
73.93K
--
--
-100.00%
0.00
-100.00%
0.00
--
1.14M
--
2.00M
Gains losses not affecting retained earnings
75.27%
-53.76K
-9.45%
-212.01K
-70.53%
-217.40K
-184.06%
-193.70K
-311.50%
-127.48K
-100.43%
-68.19K
--
-30.98K
--
-34.02K
Non-controlling interests
8232.74%
77.75K
-33.94%
-1.10K
-40.18%
-956.00
-51.38%
-822.00
-55.35%
-682.00
-72.93%
-543.00
--
-439.00
--
-314.00
Total equity
-19.57%
9.04M
-22.84%
10.16M
1817.82%
11.24M
744.70%
13.17M
-77.38%
586.30K
-56.87%
1.56M
--
2.59M
--
3.62M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up